We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current APLT market cap is 463.78M. The company's latest EPS is USD -1.1310 and P/E is -4.02.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 10.66M | 0 | 0 |
Operating Income | -19.36M | -18.97M | -10.86M | -17.18M | -15.49M |
Net Income | -19.1M | -14.43M | -10.14M | -29.58M | -42.37M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 9.99M |
Operating Income | -45.58M | -94.47M | -105.62M | -82.95M | -64.54M |
Net Income | -45.51M | -93.96M | -105.58M | -82.51M | -119.76M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 56.68M | 38.36M | 30M | 43.65M | 45.2M |
Total Liabilities | 47.05M | 34.3M | 34.08M | 47.98M | 56.24M |
Total Equity | 9.63M | 4.06M | -4.07M | -4.33M | -11.04M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 48.39M | 104.51M | 89.89M | 38.36M | 54.83M |
Total Liabilities | 15.78M | 22.57M | 27.35M | 34.3M | 71.98M |
Total Equity | 32.61M | 81.94M | 62.54M | 4.06M | -17.15M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -62.2M | -78.09M | -6.99M | -23.44M | -38.17M |
Investing | 20.08M | 13.17M | 13.87M | 13.87M | 13.87M |
Financing | 28.63M | 27.69M | -622k | 28.53M | 45.1M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -36.31M | -78.21M | -90.73M | -78.09M | -55.17M |
Investing | -20.01M | -19.47M | 12.43M | 13.17M | 13.87M |
Financing | 56.42M | 136.29M | 74.72M | 27.69M | 74.54M |
Market Cap | 463.78M |
Price to Earnings Ratio | -4.02 |
Price to Sales Ratio | 48.2 |
Price to Cash Ratio | 9.66 |
Price to Book Ratio | -28.1 |
Dividend Yield | - |
Shares Outstanding | 105.89M |
Average Volume (1 week) | 771.6k |
Average Volume (1 Month) | 899.54k |
52 Week Change | 397.73% |
52 Week High | 9.39 |
52 Week Low | 0.88 |
Spread (Intraday) | 0.02 (0.45%) |
Company Name | Applied Therapeutics Inc |
Address |
3411 silverside road tatnall wilmington, delaware 19810 |
Website | https://www.appliedtherapeutics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions